Provera · DIN 00708917 · 2.5 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-11-14 — choose a marketed DIN from the same-category list.Discontinued November 14, 2025 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-11-14 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-11-14 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Provera · DIN 00708917
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2025-11-14 · brand PROVERA 2.5MG TABLETS · ATC G03DA02 MEDROXYPROGESTERONE · form Tablet · route Oral · ingredients MEDROXYPROGESTERONE ACETATE 2.5 MG · company Pfizer canada ulc · schedule Prescription
Ministry pays: $0.1301 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00708917)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 00708917).
DIN 00708917: Provera
Raw flags: dinStatus=E, sec3=Y
Item: 683200069; group id 801; item number 1959; lccId None; manufacturer id PFI
Source form: Tab; strength: 2.5mg
Recorded listing: General benefit; DIN status E, meaning unconfirmed
Source prices (unrounded): $0.2567; ministry $0.1301
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00708917
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13037
Interchangeable products
AA-Medroxy · DIN 02244726 · $0.1301
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since November 14, 2025 — choose a marketed DIN from the same-category list.